Ratings by ThinkEquity
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 9/21/2026 | N/A | Cyabra | CYAB | New Coverage | Buy (N/A) |
1.00 (N/A) |
0.31 (0.14) |
-54.84% | Details |
| 9/8/2026 | Ashok Kumar | Annovis Bio Inc. | ANVS | Maintain | Buy (N/A) |
10.00 (20.00) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 473 more... | |||||||||
